Charterhouse-backed Cooper acquired Laboratoires Diepharmex.

Cooper, a French pharmaceutical company backed by London-based private equity investment firm Charterhouse Capital Partners, acquired Laboratoires Diepharmex, a pharmaceutical company in Geneva, Switzerland. Financial terms were not disclosed. For Cooper, owned by Charterhouse since 2015, this new acquisition grants the opportunity to seize an iconic brand in hygiene and ear care.